Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy
Under standard chemo, about 25% of patients with this genetic profile would see cancer return within three years...
Redirecting to full article...
Under standard chemo, about 25% of patients with this genetic profile would see cancer return within three years...
Redirecting to full article...